Department of Obstetrics and Gynecology, Liv Hospital Ankara, Kavaklıdere, Bestekar sokak No: 8 066680, Çankaya, Ankara, Turkey.
Department of Obstetrics and Gynecology, American Hospital, Istanbul, Turkey.
J Assist Reprod Genet. 2017 Nov;34(11):1501-1506. doi: 10.1007/s10815-017-0992-5. Epub 2017 Jul 13.
The main purpose of this study is to evaluate the inflammatory response and oxidative stress together in the cases of recurrent pregnancy loss (RPL) and repeated implantation failure (RIF).
This is a cross-sectional study conducted to compare infertile patients who have RIF and patients with RPL histories in terms of CCL2, TAS, TOS, and OSI. To this end, two study groups were formed by primary-infertile women with RIF history and women with nulliparous RPL history who consulted a university hospital between 2014 and 2016, and a control group was formed by multiparous women who had no pregnancy loss. With 30 women in each group, 90 women in total were included in the study. CCL2, TAS, and TOS blood levels were measured and oxidative stress index was calculated in all participants.
The patients with RPL and RIF had higher levels of CCL2 than those in the control group. The TOS, TAS, and OSI levels did not differ in RPL and RIF groups from the control group. No statistically significant relationship was found between CCL2 and the TOS, TAS, and OSI values.
Oxidative stress markers in the pregestational period did not have a predictive value in the RPL and RIF. CCL2 might be useful in risk prediction.
本研究的主要目的是同时评估复发性妊娠丢失(RPL)和反复着床失败(RIF)病例中的炎症反应和氧化应激。
这是一项横断面研究,旨在比较有 RIF 病史和 RPL 病史的不孕患者的 CCL2、TAS、TOS 和 OSI。为此,通过 2014 年至 2016 年间在一家大学医院就诊的原发性不孕且有 RIF 病史的妇女和初产妇且无妊娠丢失的 RPL 病史的妇女,组成了两个研究组,并形成了一个对照组,每组 30 例,共有 90 例妇女纳入研究。所有参与者均测量了 CCL2、TAS 和 TOS 血液水平,并计算了氧化应激指数。
RPL 和 RIF 患者的 CCL2 水平高于对照组。RPL 和 RIF 组的 TOS、TAS 和 OSI 水平与对照组无差异。CCL2 与 TOS、TAS 和 OSI 值之间未发现统计学显著关系。
妊娠前的氧化应激标志物在 RPL 和 RIF 中没有预测价值。CCL2 可能有助于风险预测。